0.90% 0.1431

Indivior Plc (INDV)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Indivior Plc Stock (INDV) Company Profile

Indivior Plc

Healthcare (1173)

804-379-1090

234 BATH ROAD, SLOUGH, BERKSHIRE

Nächster Verdiensttermin

Neueste SEC-Einreichungen

INDV's Discussions on Twitter

Vergleichen Sie INDV mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
INDV Indivior Plc	15.52	1.89B	1.12B	5.00M	-383.00M	0.01
ZTS Zoetis Inc	151.74	70.25B	9.29B	2.52B	2.28B	5.57
TAK Takeda Pharmaceutical Co Adr	14.70	47.44B	30.08B	710.16M	4.45B	0.2182
HLN Haleon Plc Adr	9.71	45.15B	14.35B	1.85B	0	0.4023
TEVA Teva Pharmaceutical Industries Ltd Adr	15.95	19.07B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	297.81	13.28B	2.99B	1.21B	1.13B	25.06

Indivior Plc Stock (INDV) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-01-28	Eingeleitet	Rodman & Renshaw	Buy
2024-07-23	Eingeleitet	Piper Sandler	Overweight
2024-04-03	Eingeleitet	Craig Hallum	Buy
2023-07-13	Eingeleitet	Northland Capital	Outperform

Indivior Plc Aktie (INDV) Neueste Nachrichten

Finanzdaten der Indivior Plc-Aktie (INDV)

Indivior Plc (INDV)

Indivior Plc Stock (INDV) Company Profile

Vergleichen Sie INDV mit anderen Aktien

Indivior Plc Stock (INDV) Upgrades & Downgrades

Indivior Plc Aktie (INDV) Neueste Nachrichten

Indivior stock hits 52-week high at 15.9 USD By Investing.com - Investing.com Nigeria

Indivior stock hits 52-week high at 15.9 USD - Investing.com Australia

Levi & Korsinsky Notifies Indivior PLC Investors of a Class Action Lawsuit and Upcoming DeadlineINDV - ACCESS Newswire

Hawaii to receive up to $2.4M in latest opioid settlement - spectrumlocalnews.com

Indivior Appoints Vanessa Procter as Executive Vice President of Corporate Affairs - PR Newswire

Shareholders that Lost Money on Indivior PLC (INDV) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

Indivior (INDV) Moves 5.7% Higher: Will This Strength Last? - MSN

Indivior stock hits 52-week high at $15.52 - Investing.com Australia

Indivior stock hits 52-week high at $15.52 By Investing.com - Investing.com Canada

Indivior PLC (INDV) Stock Price Up 4.02% on Jul 2 - GuruFocus

Naloxone Market Set to Witness Significant Growth by 2025-2032 | EMERGENT, Indivior PLC, Akorn, Inc - openPR.com

BlackRock Increases Stake in Indivior PLC - The Globe and Mail

Indivior to join Russell 2000 Index - MSN

Indivior PLC Announces Change in Major Holdings by Barclays - TipRanks

Indivior PLC Updates Share Capital and Voting Rights - TipRanks

Indivior price target raised to $22 from $16 at Northland - TipRanks

Indivior Announces Inclusion in the U.S. Russell 2000® and 3000® Indexes - GuruFocus

Indivior Joins U.S. Russell Indexes, Boosting Market Presence - TipRanks

Two Seas Capital LP Increases Stake in Indivior PLC - GuruFocus

Indivior Appoints Tony Kingsley to the Board of Directors – Company Announcement - Financial Times

Indivior Appoints Tony Kingsley as Non-Executive Director - TipRanks

Indivior Presents New Data at CPDD Demonstrating that High Buprenorphine Exposure May Improve Treatment Outcomes in High Fentanyl Users - StreetInsider

Indivior PLC Announces Changes in Major Holdings - TipRanks

Wirral Council v Indivior/Reckitt: Supreme Court refuses permission to appeal representative action strike out - stewartslaw.com

Indivior PLC Corrects Director Shareholding Disclosure - TipRanks

REGIndivior PLCDirector/PDMR ShareholdingCorrection - TradingView

Naloxone Market to Reflect Significant Incremental - openPR.com

Indivior Directors Increase Stake in Company Shares - TipRanks

Suboxone Market Set to Witness Growth as Opioid Dependency - openPR.com

Substance Abuse Treatment Market Size, Trends & Growth - openPR.com

Indivior PLC Announces Changes in Major Shareholdings - MSN

Indivior-Funded Study Suggests Opvee Outperforms Narcan. But at What? - Filter

INDV DEADLINE ALERT: Bernstein Liebhard LLP Reminds Indivior PLC Investors of Upcoming Deadline - ACCESS Newswire

Indivior PLC (INDV) Stock Analysis: Exploring a 9.21% Potential Upside Amidst Strategic Developments - DirectorsTalk Interviews

Suboxone Market Is Booming Nationwide with New Formulations - openPR.com

Shareholders that lost money on Indivior PLC(INDV) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More - ACCESS Newswire

Indivior PLC Announces Change in Major Shareholder Holdings - TipRanks

Levi & Korsinsky Notifies Shareholders of Indivior PLC(INDV) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

Substance Abuse Treatment Market Set to Witness Digital and Personalized Care Expansion | Indivior, Alkermes - openPR.com

Addex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference - GlobeNewswire Inc.

Indivior to delist from London Stock Exchange, maintain primary listing on Nasdaq - MSN

Indivior PLC (INDV) Stock Analysis: Evaluating the 17.71% Potential Upside Amidst Market Challenges - DirectorsTalk Interviews

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Indivior PLC To Contact The Firm - ACCESS Newswire

Indivior’s exit comes as no surprise - The Times

Indivior PLC (INDV) Stock Price Down 3.27% on Jun 2 - GuruFocus

Opioid Use Disorder Market Projected to Witness Massive GrowthIndivior PLC, Alkermes plc - openPR.com

Trending tickers: The latest investor updates on Tesla, Palantir, Sanofi, Babcock and Indivior - Yahoo

Kalkine : Indivior’s Exit from London Exchange Impacts FTSE 100 Pharmaceutical Landscape - Kalkine Media

Indivior to delist from London Stock Exchangewill stay on Nasdaq - Insider Media Ltd

Drug maker Indivior joins London Stock Exchange exodus, 2 Jun 2025 11:00 - Shares Magazine

Kalkine : Indivior’s FTSE 100 Sector Shift: Delisting from London to Focus on Nasdaq Listing - Kalkine Media

Finanzdaten der Indivior Plc-Aktie (INDV)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie INDV